| Literature DB >> 33505424 |
Luyan Zhang1, Fan Yang1, Mei Chen1, Ming Zhou1, Tianwei Qian1, Mohammed Omer Mujtaba1, Abdul Haseeb Mohammed1, Jie Yin1, Xueying Cheng1, Jinlong Chen1, Yuming Qin1, Shiwei Yang1.
Abstract
Danon disease (DD) is a monogenic lysosomal storage disorder characterized by cardiomyopathy, skeletal myopathy, and variable degrees of intellectual disability. It is caused by a deficiency of lysosomal-associated membrane protein 2 (LAMP2). Two unrelated boys who presented with severe hypertrophic cardiomyopathy and elevated levels of liver enzymes, and were diagnosed with Danon disease at a very young age, were investigated. One boy was diagnosed at 4 months old and died soon after; his mother also died of hypertrophic cardiomyopathy shortly after his birth. Another developed hypertrophic cardiomyopathy at 3 months old but reported no significant cardiovascular symptoms during more than 5 years follow-up. Genetic screening found compound variants of LAMP2 and MYH7 in both of them. This report highlights the clinical heterogeneity in DD. The timely identification of LAMP2 mutation plays a critical role in their treatment and family counseling.Entities:
Keywords: Danon disease; LAMP2; MYH7; genetics; hypertrophic cardiomyopathy
Year: 2021 PMID: 33505424 PMCID: PMC7831386 DOI: 10.3389/fgene.2020.589838
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599